SUN PHARMACEUTICAL INDUSTRIES LTD. - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Additional Information On Dadra Facility Receives Warning Letter From USFDA